Novel patterns of p53 abnormality in breast cancer from Taiwan: Experience from a low-incidence area

British Journal of Cancer

Volumn 75, Issue 5, 1997, Pages 746-751

  Lou, M Ann ^a   Tseng, Su Ling ^b   Chang, Shu Fen ^b   Yue, Chung Tai ^c   Chang, Bao Li ^b   Chou, Chi How ^b   Yang, Show Lin ^b   Teh, Bee Heong ^b   Wu, Cheng Wen ^b   Shen, Chen Yang ^b  

^a CARDINAL TIEN HOSPITAL   (Taiwan)

^b INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

^c MACKAY MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Breast; Cancer; Human; p53

Indexed keywords

PROTEIN P53;

ARTICLE; BREAST CANCER; CANCER INCIDENCE; CONTROLLED STUDY; FEMALE; GENE MUTATION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; TAIWAN; TUMOR SUPPRESSOR GENE;

EID: 8044222151     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1997.132     Document Type: Article

References (17)

1. Cariello NF, Cui L, Beroud C and Soussi T (1994) Database and software for the analysis of mutations in the human p53 gene. Cancer Res, 54: 4454-4460 (This dataset has been updated by us, adding mutations published in 1995-96)
2. Cho Y, Gorina S, Jeffrey PD and Pavletich NP (1994) Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations. Science 265: 346-355
3. 1 arrest and apoptosis. Cancer Res 54: 1169-1174
4. Greenblatt MS, Bennett WP, Hollstein M and Harris CC (1994) Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res 54: 4855-4878
5. Greenblatt MS, Grollman AP and Harris CC (1996). Deletions and insertions in the p53 tumor suppressor gene in human cancers: confirmation of the DNA polymerase slippage/ misalignment model. Cancer Res 56: 2130-2136
6. Hall PA and Lane DP (1994) p53 in tumor pathology: can we trust immunohistochemistry: revisited. J Pathol 172: 1-4
7. Liu RH and Hotchkiss JH (1995). Potential genotoxicity of chronically elevated nitric oxide: a review. Mutation Res 339: 73-89
8. Moll UM, Riou G and Levine AJ (1992) Two distinct mechanisms alter p53 in breast cancer: mutation and nuclear exclusion. Proc Natl Acad Sci USA 89: 7262-7266
9. Momand J, Zambetti GP, Olson DC, George D and Levine AJ (1992) The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell 69: 1237-1245
10. Orita M, Iwahana H, Kanazawa H, Hayashi K and Sekiya T (1989) Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms. Proc Natl Acad Sci USA 86: 2766-2770
11. Pike MC, Spicer DV, Dahmoush L and Press MF (1993) Estrogens, progestogens. normal breast cell proliferation, and breast cancer risk. Epidemiol Rev 15: 17-35
12. Ripley LS (1990). Frameshift mutation: determinants of specificity. Annu Rev Genet 24: 189-213
13. Shen CY, HO MS, Chang SF, Yen MS, Ng HT, Huang ES and Wu CW, High rate of concurrent genital infections with human cytomegalovirus and human papillomaviruses in cervical cancer patients (1993) J Infect Dis 168: 449-452
14. Shen JC, Rideout WM, III and Jones PA (1992) High frequency mutagenesis by a DNA methyltransferase. Cell 71: 1073-1080
15. Speir E, Modali R, Huang ES, Leon MB, Shawl F Finkel T and Epstein SE (1994) Potential role of human cytomegalovirus and p53 interaction in coronary restenosis. Science 265: 391-394
16. Wink DA, Kasprzak KS, Maragos CM, Elespuru RK, Misra M, Dunams TM, Cebula TA, Koch WH, Andrews AW, Allen JS and Keefer LK (1991) DNA deaminating ability and genotoxicity of nitric oxide and its progenitors. Science 254: 1001-1003.
17. Yang PS, Yang TL, Liu CL, Wu CW and Shen CY (1997) Risk factors for breast cancer in Taiwan-experience from a low-incidence area. Br J Cancer 75: 752-756